3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Barrett Esophagus
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Colorectal Neoplasms
2
Thyroid Nodule
1
Recurrence
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Inflammatory Bowel Diseases
1
Hypertension, Portal
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Gemcitabine
6
130-nm albumin-bound paclitaxel
4
S 1 (combination)
2
Radiosurgery
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Electroporation
2
zimberelimab
1
surufatinib
1
Tomography, X-Ray Computed
1
Pancreatectomy
1
Irinotecan
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Endoscopy
1
Drug Therapy
1
Diagnostic Imaging
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Pancreatic Cancer
×
Diagnostic Imaging
×
Gastrointestinal
×
Clear all
NCT06944587
2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
400 enrolled